We are live on ! Find out more
DA

Duality Advisers Portfolio holdings

AUM $1.01B
1-Year Est. Return 14.52%
This Fund
S&P 500
This Quarter Est. Return
-19.17%
1 Year Est. Return
+14.52%
3 Year Est. Return
-18.25%
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$82.9M
Cap. Flow
+$254M
Cap. Flow %
24.99%
Top 10 Hldgs %
5.89%
Holding
929
New
322
Increased
166
Reduced
83
Closed
358

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$5.73M
2
AIZ icon
Assurant
AIZ
+$5.72M
3
VZ icon
Verizon
VZ
+$5.72M
4
CVS icon
CVS Health
CVS
+$5.71M
5
UGI icon
UGI
UGI
+$5.69M

Sector Composition

Rank Sector Weight
1 Healthcare 15.67%
2 Industrials 15.54%
3 Technology 14.54%
4 Consumer Discretionary 12.65%
5 Financials 12.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
101
BCE
BCE
$20B
$3M 0.3%
61,069
+42,081
+222% +$2.26M
ACAD icon
102
Acadia Pharmaceuticals
ACAD
$4.34B
$3M 0.3%
213,094
+190,976
+863% +$3.56M
SAIA icon
103
Saia
SAIA
$11B
$3M 0.3%
15,960
+9,884
+163% +$1.99M
BBWI icon
104
Bath & Body Works
BBWI
$4.08B
$3M 0.3%
111,392
+58,395
+110% +$2.53M
TSLA icon
105
Tesla
TSLA
$1.21T
$3M 0.3%
13,353
+4,494
+51% +$1.23M
HIW icon
106
Highwoods Properties
HIW
$3.74B
$2.99M 0.29%
+87,406
New +$3.45M
SPOT icon
107
Spotify
SPOT
$100B
$2.98M 0.29%
+31,803
New +$3.59M
DVN icon
108
Devon Energy
DVN
$50.6B
$2.98M 0.29%
54,101
+39,140
+262% +$2.56M
AMD icon
109
Advanced Micro Devices
AMD
$793B
$2.97M 0.29%
38,884
+13,348
+52% +$1.25M
BBBY
110
Bed Bath & Beyond
BBBY
$492M
$2.97M 0.29%
+130,461
New +$3.92M
VIR icon
111
Vir Biotechnology
VIR
$1.5B
$2.96M 0.29%
116,415
+58,520
+101% +$1.37M
ITCI
112
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.96M 0.29%
+51,825
New +$2.94M
BBY icon
113
Best Buy
BBY
$18.4B
$2.95M 0.29%
45,215
+2,563
+6% +$214K
HZNP
114
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.94M 0.29%
+36,912
New +$3.5M
SIVB
115
DELISTED
SVB Financial Group
SIVB
$2.93M 0.29%
7,420
+6,792
+1,082% +$3.2M
CRL icon
116
Charles River Laboratories
CRL
$10.9B
$2.91M 0.29%
13,609
+7,690
+130% +$1.88M
USFD icon
117
US Foods
USFD
$21.7B
$2.88M 0.28%
+93,920
New +$3.18M
CRSP icon
118
CRISPR Therapeutics
CRSP
$4.66B
$2.87M 0.28%
47,284
+29,132
+160% +$1.71M
TNDM icon
119
Tandem Diabetes Care
TNDM
$1.17B
$2.87M 0.28%
48,461
+44,694
+1,186% +$3.67M
BRK.B icon
120
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.87M 0.28%
+10,498
New +$3.29M
DAL icon
121
Delta Air Lines
DAL
$56.7B
$2.86M 0.28%
+98,706
New +$3.76M
CHH icon
122
Choice Hotels
CHH
$5.09B
$2.86M 0.28%
25,609
+13,549
+112% +$1.76M
CLH icon
123
Clean Harbors
CLH
$16B
$2.85M 0.28%
+32,563
New +$3.14M
TEVA icon
124
Teva Pharmaceuticals
TEVA
$36.2B
$2.84M 0.28%
+378,036
New +$3.29M
EQT icon
125
EQT Corp
EQT
$32.8B
$2.82M 0.28%
+81,885
New +$3.38M

Similar funds

Duality Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Duality Advisers held 929 positions worth $1.01B, up 8.9% from $932M the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Duality Advisers deployed $254M of net new capital in Q2 2022, opening 322 new positions and adding to 166 existing holdings. Its largest new stake was CSX Corp: 205,681 shares worth $5.98M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Simon Property Group, an estimated $4.3M trimmed.

  • Duality Advisers's largest Q2 2022 buy was CSX Corp: 205,681 shares worth $5.98M.
  • Duality Advisers added most to Healthpeak Properties in Q2 2022, an estimated $6.33M increase.
  • Duality Advisers's biggest Q2 2022 reduction was Simon Property Group, cutting an estimated $4.3M.
  • Duality Advisers fully exited Colgate-Palmolive in Q2 2022, selling an estimated $5.73M.
  • Duality Advisers's ten largest holdings make up 5.9% of its $1.01B portfolio in Q2 2022.
  • Duality Advisers opened 322 new positions and closed 358 in Q2 2022.
  • Duality Advisers's portfolio value rose 8.9% quarter-over-quarter to $1.01B.

Based on Duality Advisers's 13F filing for Q2 2022, filed 8 Aug 2022.